{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:00:48Z","timestamp":1787065248227,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,20]]},"DOI":"10.7759\/cureus.74080","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:45:00Z","timestamp":1732092300000},"source":"Crossref","is-referenced-by-count":4,"title":["Chronic Lymphocytic Leukemia Infiltrating in the Brain"],"prefix":"10.7759","author":[{"given":"Lauren M","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad S","family":"Kenderian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelco F","family":"Wijdicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12659","article-title":"Differences in incidence and trends of haematological malignancies in Japan and the United States","volume":"164","author":"Chihara D","year":"2014","unstructured":"Chihara D, Ito H, Matsuda T, et al.. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014, 164:536-45. 10.1111\/bjh.12659","journal-title":"Br J Haematol"},{"key":"ref2","unstructured":"Key statistics for chronic lymphocytic leukemia. (2024). Accessed. 10\/29\/2024: https:\/\/www.cancer.org\/cancer\/types\/chronic-lymphocytic-leukemia\/about\/key-statistics.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.06.003","article-title":"Chronic lymphocytic leukaemia","volume":"104","author":"Scarf\u00f2 L","year":"2016","unstructured":"Scarf\u00f2 L, Ferreri AJ, Ghia P. Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol. 2016, 104:169-82. 10.1016\/j.critrevonc.2016.06.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst B","year":"2021","unstructured":"Eichhorst B, Robak T, Montserrat E, et al.. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021, 32:23-33. 10.1016\/j.annonc.2020.09.019","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel RL","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021, 71:7-33. 10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek M","year":"2019","unstructured":"Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol. 2019, 94:1266-87. 10.1002\/ajh.25595","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.481","article-title":"Understanding and managing ultra high-risk chronic lymphocytic leukemia","volume":"2010","author":"Stilgenbauer S","year":"2010","unstructured":"Stilgenbauer S, Zenz T. Understanding and managing ultra high-risk chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2010, 2010:481-8. 10.1182\/asheducation-2010.1.481","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002847","article-title":"Chronic lymphocytic leukaemia: rare involvement of the central nervous system","volume":"8","author":"Amado C","year":"2021","unstructured":"Amado C, Duarte V, Silva Leal M, Cruz M, Ferreira G. Chronic lymphocytic leukaemia: rare involvement of the central nervous system. Eur J Case Rep Intern Med. 2021, 8:002847. 10.12890\/2021_002847","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_442_17","article-title":"Chronic lymphocytic leukemia involvement of central nervous system: clinical diversity, diagnostic algorithm and therapeutic challenges","volume":"21","author":"Mihaljevic B","year":"2018","unstructured":"Mihaljevic B, Smiljanic M, Antic D, Kurtovic NK, Balint MT. Chronic lymphocytic leukemia involvement of central nervous system: clinical diversity, diagnostic algorithm and therapeutic challenges. Ann Indian Acad Neurol. 2018, 21:85-7. 10.4103\/aian.AIAN_442_17","journal-title":"Ann Indian Acad Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14387","article-title":"Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients","volume":"176","author":"Wanquet A","year":"2017","unstructured":"Wanquet A, Birsen R, Bonnet C, et al.. Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients. Br J Haematol. 2017, 176:37-49. 10.1111\/bjh.14387","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.136556","article-title":"Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia","volume":"101","author":"Strati P","year":"2016","unstructured":"Strati P, Uhm JH, Kaufmann TJ, et al.. Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia. Haematologica. 2016, 101:458-65. 10.3324\/haematol.2015.136556","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-011-0636-z","article-title":"Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review","volume":"106","author":"Moazzam AA","year":"2012","unstructured":"Moazzam AA, Drappatz J, Kim RY, Kesari S. Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review. J Neurooncol. 2012, 106:185-200. 10.1007\/s11060-011-0636-z","journal-title":"J Neurooncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3660","article-title":"Central nervous system lymphoma in a patient with chronic lymphocytic leukemia: a case report and literature review","volume":"10","author":"Albakr A","year":"2018","unstructured":"Albakr A, Alhothali W, Samghabadi P, Maeda L, Nagpal S, Ajlan A. Central nervous system lymphoma in a patient with chronic lymphocytic leukemia: a case report and literature review. Cureus. 2018, 10:e3660. 10.7759\/cureus.3660","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pjnns.2017.10.012","article-title":"Central nervous involvement by chronic lymphocytic leukaemia","volume":"52","author":"Szczepanek D","year":"2018","unstructured":"Szczepanek D, W\u0105sik-Szczepanek E, Szymczyk A, et al.. Central nervous involvement by chronic lymphocytic leukaemia. Neurol Neurochir Pol. 2018, 52:228-34. 10.1016\/j.pjnns.2017.10.012","journal-title":"Neurol Neurochir Pol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/21.081","article-title":"Chronic lymphocytic leukemia with leptomeningeal involvement presenting as an acute encephalopathy","volume":"26","author":"Bae WH","year":"2022","unstructured":"Bae WH, Yee M, Song L, Canonico MM, Verhoef PA, Shimabukuro KA. Chronic lymphocytic leukemia with leptomeningeal involvement presenting as an acute encephalopathy. Perm J. 2022, 26:126-31. 10.7812\/TPP\/21.081","journal-title":"Perm J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.190132","article-title":"Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways","volume":"103","author":"Abruzzo LV","year":"2018","unstructured":"Abruzzo LV, Herling CD, Calin GA, et al.. Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways. Haematologica. 2018, 103:2069-78. 10.3324\/haematol.2018.190132","journal-title":"Haematologica"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3905","article-title":"Difficult-to-treat syndrome of inappropriate antidiuretic hormone secretion in a patient with secondary central nervous system lymphoma","volume":"11","author":"Joshi H","year":"2019","unstructured":"Joshi H, Nagumantry S, Pierres F, Oyibo SO, Sagi SV. Difficult-to-treat syndrome of inappropriate antidiuretic hormone secretion in a patient with secondary central nervous system lymphoma. Cureus. 2019, 11:e3905. 10.7759\/cureus.3905","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2018.65148","article-title":"Unusual combined cause of Takotsubo cardiomyopathy: hyponatremia and seizure","volume":"6","author":"Simsek EC","year":"2019","unstructured":"Simsek EC, Emren SV, Ozdogan O. Unusual combined cause of Takotsubo cardiomyopathy: hyponatremia and seizure. North Clin Istanb. 2019, 6:304-7. 10.14744\/nci.2018.65148","journal-title":"North Clin Istanb"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy288","article-title":"Clinical significance of human herpesvirus 6 positivity on the FilmArray meningitis\/encephalitis panel","volume":"67","author":"Green DA","year":"2018","unstructured":"Green DA, Pereira M, Miko B, Radmard S, Whittier S, Thakur K. Clinical significance of human herpesvirus 6 positivity on the FilmArray meningitis\/encephalitis panel. Clin Infect Dis. 2018, 67:1125-8. 10.1093\/cid\/ciy288","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/imj.16279","article-title":"Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies","volume":"54","author":"Crassini K","year":"2024","unstructured":"Crassini K, Gibson J. Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies. Intern Med J. 2024, 54:16-25. 10.1111\/imj.16279","journal-title":"Intern Med J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000523858","article-title":"Venetoclax: a novel therapeutic agent for CLL with CNS involvement","volume":"15","author":"Karbhari N","year":"2022","unstructured":"Karbhari N, Lara-Martinez H, Hill JM Jr. Venetoclax: a novel therapeutic agent for CLL with CNS involvement. Case Rep Oncol. 2022, 15:345-50. 10.1159\/000523858","journal-title":"Case Rep Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.472.472","article-title":"Phase I study of dose-adjusted-Teddi-R with ibrutinib in untreated and relapsed\/refractory primary CNS lymphoma","volume":"126","author":"Dunleavy K","year":"2015","unstructured":"Dunleavy K, Lai CE, Roschewski M, et al.. Phase I study of dose-adjusted-Teddi-R with ibrutinib in untreated and relapsed\/refractory primary CNS lymphoma. Blood. 2015, 126:472. 10.1182\/blood.V126.23.472.472","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0619","article-title":"Leptomeningeal carcinomatosis in chronic lymphocytic leukemia: a case report and review of the literature","volume":"24","author":"Naydenov AV","year":"2019","unstructured":"Naydenov AV, Taylor LP. Leptomeningeal carcinomatosis in chronic lymphocytic leukemia: a case report and review of the literature. Oncologist. 2019, 24:1237-45. 10.1634\/theoncologist.2018-0619","journal-title":"Oncologist"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306570-chronic-lymphocytic-leukemia-infiltrating-in-the-brain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:45:06Z","timestamp":1732092306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306570-chronic-lymphocytic-leukemia-infiltrating-in-the-brain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.74080","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}